Healthtech Startups

PrecisionBiotics develops food supplements containing specific bacterial strains aimed at supporting gut health and the microbiome for consumers and clinicians, alongside educational resources on gut health. The company originated from microbiome research with the APC Microbiome Institute at UCC in Ireland and is now part of the Novonesis Group.

1 investor

Precision Microbubbles develops the M Sorter, a benchtop device that purifies commercially available microbubble suspensions into uniform-sized populations for scientific and medical applications. The device is designed for researchers and clinicians who require consistent, monodisperse microbubbles without complex synthesis processes.

1 investor

PrecisionCare AI develops sensing technology and analytics for physical therapy to provide objective measurement of soft tissue treatment. The platform serves clinicians and health systems seeking to improve therapeutic precision and outcomes at scale.

1 investor

Precision Cell Systems is a company that provides products and services related to genomics and cell/biology research, offering resources, webinars, and product ordering through its website. The available page is a privacy policy and does not describe the specific products in detail.

1 investor

PrecisionLife uses advanced AI and analytics to identify the biological mechanisms underlying complex chronic diseases, enabling earlier diagnosis and more personalized treatment selection. The company develops diagnostic tests, clinical tools, and insights for pharmaceutical and healthcare partners to improve disease understanding and patient outcomes across multiple therapeutic areas.

1 investor

PrecisionPhage develops computational and laboratory solutions for bacteriophage research to address antimicrobial resistance. The company creates bioinformatics tools and phage-based technologies intended for healthcare and biotech applications globally.

1 investor

PRECISIS develops bioelectronic therapies for neurological conditions, including EASEE, a minimally invasive neurostimulation system implanted under the scalp to treat drug-resistant focal epilepsy without brain surgery. The company targets patients with medication-resistant epilepsy and the medical professionals who treat them.

1 investor

Precuro offers Cognitive Risk Intelligence (CRI), a non-clinical assessment that measures how individuals respond to pressure and uncertainty and turns those patterns into a forward-looking behavioral signal predicting claim duration, cost, and complexity. It serves insurers, captives, and reinsurers, with primary applications in disability insurance and workers' compensation across claims triage, underwriting, and portfolio-level risk analysis.

1 investor

Predicta Med develops a data analytics platform using deep learning to identify at-risk autoimmune disease patients across multiple medical systems, enabling clinicians to intervene earlier and improve diagnostic outcomes.

1 investor

1 investor

Predictiv Care uses DNA and genomic analysis to identify genetic predispositions so diseases can be predicted and prevented, with a focus on personalized, preventive health. The company aims to make precision and preventive healthcare affordable and understandable for individuals.

1 investor

DrugPatentWatch provides biopharmaceutical intelligence drawn from primary sources such as the USPTO, FDA Orange Book, ANDA filings, litigation records, and patent registers across 134 countries, covering drug patents, pipelines, litigation, and pricing. It serves pharmaceutical professionals including generics manufacturers, biotech firms, and distributors, offering continuously updated, exportable data for competitive and market analysis.

1 investor

Predictive Wear develops wearable hydration-monitoring technology that integrates sensors into textiles and uses a deep learning algorithm, HydraNet, to estimate hydration status in real time from the body's electrical resistance. The product targets athletes who need to track and maintain hydration during competition.

1 investor

PrediSurge develops AI-powered digital twin technology that converts CT scans into patient-specific models to help clinicians plan and execute cardiovascular interventions, particularly aortic endovascular repairs. The company serves vascular surgeons and medical device manufacturers seeking to enhance surgical precision and patient outcomes through predictive, simulation-based decision support.

1 investor

PreDxion Bio develops rapid diagnostic tests using saliva samples and a scalable semiconductor-based platform, initially targeting SARS-CoV-2 detection for asymptomatic and presymptomatic individuals, with broader applications in monitoring immune response markers in critically ill patients and predicting complications from cell therapies.

1 investor

Preemptive builds a continuous, clinician-guided health monitoring layer positioned beneath primary care, using sensing and AI to detect early physiological changes before symptoms appear. It combines device signals with human interpretation to provide early health signals for individuals within the broader healthcare system.

1 investor

Preface Health provides a patient follow-up and engagement platform that helps healthcare organizations guide patients through care journeys, from post-visit follow-up to appointment scheduling and care coordination. The platform serves primary care, urgent care, specialty care, and health systems to improve patient retention and care continuity.

1 investor

Smart Human Dynamics develops Pregnancy Coach, a digital health platform that monitors physiological metrics and recommends behaviors to reduce pregnancy complications for expectant mothers. The company focuses on preventing preeclampsia, stillbirth, preterm birth, and other obstetric risks.

1 investor

Prehensile Technologies designs robotic assistive devices, including RoboTable (a robotic overbed table for beds, recliners, and wheelchairs) and RoboDesk (a robotic wheelchair mount), that let users independently deploy, position, and store mobile devices via remote or accessible switches. It also offers custom assistive technology design, prototyping, and testing services to enhance independence for people with mobility limitations.

1 investor

Prelude Fertility operates a network of partnerships connecting aspiring parents with fertility treatment providers, including donor egg banks, financial bundling services, virtual pharmacy services, and reproductive health supplements.

1 investor

Premise Health delivers occupational and primary care health services to large employers through on-site clinical delivery and enterprise integration of healthcare operations. The company provides services including primary care, occupational health, pharmacy, and behavioral health programs.

1 investor

Prenosis develops AI-powered precision medicine diagnostics for acute care, built on its Immunix platform and a biobank of clinical data for infection. Its Sepsis ImmunoScore is an FDA-authorized AI diagnostic that integrates biomarkers and clinical data into hospital electronic medical records to diagnose sepsis and predict patient outcomes.

1 investor

Prepared provides a competency-based assessment system for medical and professional trainees to develop workplace-relevant skills. The platform serves medical education institutions and training programs adopting competency-based education models.

1 investor

Presage Technologies offers SmartSpectra, a contactless health-sensing SDK that turns any smartphone camera or webcam into a real-time biometric sensor, extracting vital signs such as heart rate, breathing rate, HRV, and facial expressions without wearables or contact sensors. It targets developers, hospitals, clinics, and health organizations, with FDA 510(k) clearance for heart rate and breathing rate on iOS and Android.

1 investor